HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Legionellosis in a lung transplant recipient obscured by cytomegalovirus infection and Clostridium difficile colitis.

Abstract
A 52-year-old-white male underwent double lung transplantation for severe emphysema due to alpha-1-antitrypsin deficiency and heavy tobacco use. Following a postoperative course complicated by renal insufficiency, pulmonary emboli, and Clostridium difficile colitis, he was discharged in stable condition. Two months later, he was admitted to a local hospital with a fever, abdominal pain, diarrhea, nausea, and dyspnea. Computerized tomography (CT) of the chest revealed bilateral pleural effusions. Sigmoidoscopy was grossly normal but biopsy demonstrated cytomegalovirus (CMV) colitis, and the patient was placed on intravenous ganciclovir. Over the next week, he became progressively hypoxemic and was transferred to the University of Pittsburgh Medical Center (post-transplant day 81) for further evaluation. His medications on transfer included: ganciclovir, prednisone, tacrolimus, dapsone, fluconazole, ondansetron, lansoprazole, digoxin, and coumadin.
AuthorsL Nichols, D C Strollo, S Kusne
JournalTransplant infectious disease : an official journal of the Transplantation Society (Transpl Infect Dis) Vol. 4 Issue 1 Pg. 41-5 (Mar 2002) ISSN: 1398-2273 [Print] Denmark
PMID12123425 (Publication Type: Case Reports, Journal Article)
Topics
  • Bronchoalveolar Lavage Fluid (microbiology)
  • Clostridium Infections (complications)
  • Colitis (complications)
  • Cytomegalovirus Infections (complications)
  • Fatal Outcome
  • Humans
  • Legionella pneumophila (isolation & purification)
  • Legionnaires' Disease (complications, diagnostic imaging, microbiology)
  • Lung Transplantation
  • Male
  • Middle Aged
  • Postoperative Complications
  • Radiography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: